Hemeflix

Meet The Professor - How to improve prognosis in Myelofibrosis?

Mieloproliferativas

MF e PV

Neste vídeo o Dr. Verstovsek discute novas evidencias sobre o impacto do Rux na sobrevida de pacientes com mielofibrose

Sobre o(s) palestrante(s)

Dr. Srdan Verstovsek

Dr. Srdan Verstovsek

Professor of Medicine and hematologist-oncologist at MD Anderson (EUA). Dr. Verstovsek is a global leader in myeloproliferative neoplasms (MPN)

Relacionados

Cookie Settings